On December 3, Gelonghui reported that cathay biotech inc. (688065.SH) announced that it recently received the "Approval from the China Securities Regulatory Commission for the Registration of Shares Issued by Shanghai Cathay Biotechnology Co., Ltd. to Specific Objects" (Securities Regulatory License [2024] No. 1662). The content of the approval document is as follows:

1. Approve your company's registration application for issuing stocks to specific parties. 2. Your company should strictly implement the submitted application documents and issuance plan to the Shanghai Stock Exchange. 3. This approval is valid for 12 months from the date of registration.